Trulieve Cannabis subsidiary named as tenant at Houston retail site
A property memorandum links a Washington Avenue retail renovation to Trulieve TX Inc.; a Texas accessibility review does not authorize cannabis sales.
Theo Marchetti
Texas's Department of Licensing and Regulation listed an April 17 filing for a 5,637-square-foot Houston retail renovation as "Review Complete" when checked Oct. 8. Trulieve Cannabis Corp. NYSETRLV is linked to the 2420 Washington Avenue site by a property offering memorandum naming Trulieve TX Inc. as tenant.
Trulieve shares closed at US$10.37, down 3.8 per cent, on the New York Stock Exchange at 4 p.m. EDT on Oct. 8 NYSETRLV. The accessibility review is a construction record; it does not permit medical cannabis sales.
The property memorandum identifies Trulieve Holdings Inc. as lease guarantor and calls it a wholly owned subsidiary of the listed company. It describes a retail property offered for sale, with tenant renovation and buildout in progress. The broker's memorandum, rather than the state accessibility file, supplies the site-specific corporate connection.
The Texas Department of Public Safety's Dec. 1, 2025 notice named Trulieve TX Inc. among nine businesses selected for conditional licensing under House Bill 46. DPS assigned the applicant to Public Health Region 1 and said final authorization required further due diligence. Its notice did not identify the Washington Avenue property as an approved dispensary.
"Conditional licenses do not grant the applicant permission to cultivate, manufacture, distribute or sell cannabis products until final approval by the department," DPS said in its Dec. 1 notice.
The Filing Records an Accessibility Review
The state file describes a proposed renovation of existing retail space. Its "Review Complete" status was visible Oct. 8 in the architectural barriers register. The project name contains Trulieve, but the record does not identify Trulieve Cannabis Corp. or Trulieve TX Inc. in its owner or tenant fields. It does not establish that the site has opened.
The broker describes a five-year lease with two five-year renewal options and labels Sept. 18, 2026 as the estimated rent commencement date. That estimate does not show that rent began then. The memorandum markets the property for sale and gives the broker's account of the lease; the lease itself was not among the documents reviewed.
DPS Controls Cannabis Sales Approval
House Bill 46 authorized 12 additional dispensing organization licences across two selection phases, according to DPS's December notice. That count concerns the Texas program, while the Washington Avenue filing concerns accessibility at one property. Neither the state project status nor the broker's description establishes that patients can buy cannabis there.
DPS said it would examine applicants' disciplinary history, finances and litigation before final approval. It warned that conditional selection did not guarantee a licence and that dispensing organization fees would not be invoiced until due diligence was complete.
Read more: Trulieve Cannabis Corp repays US$65M Florida mortgage before maturity
DPS's Dec. 1, 2025 notice set no date for a final decision on Trulieve TX's conditional selection. DPS said final approval, rather than the Houston accessibility status, would be required before the company could sell medical cannabis in Texas.
